Atlas Trials

Allo HSCT Using RIC and PTCy for Hematological Diseases

Clinical trial NCT05805605 · RECRUITING

Trial details

NCT number
NCT05805605
Sponsor
Masonic Cancer Center, University of Minnesota
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute LeukemiaUndifferentiated LeukemiaProlymphocytic LeukemiaChronic Myelogenous LeukemiaPlasma Cell LeukemiaMyelodysplastic SyndromesLeukemia, MyeloidMyelodysplastic Syndrome With Excess Blasts-1Burkitt LymphomaRelapsed T-Cell Lymphoma
Start date
2023-05-01
Primary completion
2027-10-22
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.